Literature DB >> 1587137

Corneal argyrosis associated with silver soldering.

M W Scroggs1, J S Lewis, A D Proia.   

Abstract

We report a patient who developed corneal argyrosis secondary to occupational silver soldering. Clinically, the cornea was notable for a green-brown discoloration localized to Descemet's membrane by slit-lamp biomicroscopy. Silver particles were identified within the anterior three eighths of Descemet's membrane by light and electron microscopy and energy-dispersive x-ray microanalysis. To our knowledge, the association between corneal argyrosis and silver soldering has not been previously reported.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587137

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  6 in total

1.  Re-examining digoxin bioavailability after half a century: Time for changes in the bioavailability concepts.

Authors:  Athanasios A Tsekouras; Panos Macheras
Journal:  Pharm Res       Date:  2021-10-18       Impact factor: 4.200

2.  Ocular argyrosis secondary to long-term ingestion of silver nitrate salts.

Authors:  Kesenia Stafeeva; Michael Erlanger; Raul Velez-Montoya; Jeffrey L Olson
Journal:  Clin Ophthalmol       Date:  2012-12-05

3.  A pharmacological and toxicological profile of silver as an antimicrobial agent in medical devices.

Authors:  Alan B G Lansdown
Journal:  Adv Pharmacol Sci       Date:  2010-08-24

Review 4.  Clinical and Forensic Aspects of the Different Subtypes of Argyria.

Authors:  Luís Mota; Ricardo Jorge Dinis-Oliveira
Journal:  J Clin Med       Date:  2021-05-13       Impact factor: 4.241

5.  A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles.

Authors:  Gerald Bachler; Natalie von Goetz; Konrad Hungerbühler
Journal:  Int J Nanomedicine       Date:  2013-09-02

6.  Fracture strength of different soldered and welded orthodontic joining configurations with and without filling material.

Authors:  Jens Johannes Bock; Jacqueline Bailly; Christian Ralf Gernhardt; Robert Andreas Werner Fuhrmann
Journal:  J Appl Oral Sci       Date:  2008 Sep-Oct       Impact factor: 2.698

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.